Pharmacophore an International Research Journal
Currently, iron deficiency anemia (IDA) is one of the most common in the world and extremely dangerous for women's health group of diseases, especially during pregnancy. It is proved that in patients from fifteen to forty-five years of age, 80% of all cases of blood diseases are due to anemia. With age, as a rule, the female body's need for iron increases. Anemia in pregnant women is iron-deficient in more than ninety percent of cases and requires careful monitoring of the entire period of pregnancy. In this article, a systematic online literature search was conducted in MEDLINE (National Medical Library), including PubMed, Web of Science, and Cochrane. The bibliographies of the relevant publications have been checked for further study. The cases of 130 pregnant and recently delivered patients were analyzed, their average age was thirty-two years. After a single intravenous administration of iron carboxymaltosate, there were more pronounced dynamics of hematological and ferrokinetic blood parameters compared with oral administration of iron (III) hydroxide polymaltosate for a month. Observation of patients after childbirth and during lactation confirmed the effectiveness of the applied medical measures. IDA in the female body can have a long-term, reaching a chronic stage, negative effect on the female body, starting from adolescence, therefore, early recognition and treatment of this clinical condition are fundamental in world and domestic medical practice.
